This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| ABRDN PLC | 152.4 | 7.6% |
| SMITH & NEPHEW PLC | 1,078.0 | 6.1% |
| PRUDENTIAL PLC | 932.6 | 5.8% |
| SEGRO PLC | 938.0 | 5.2% |
| ROLLS-ROYCE HOLDINGS PLC | 75.0 | 5.1% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| BERKELEY GROUP HOLDINGS/THE | 3487.0 | -2.8% |
| PERSIMMON PLC | 1435.5 | -2.4% |
| BARRATT DEVELOPMENTS PLC | 407.5 | -1.9% |
| NATIONAL GRID PLC | 1070.0 | -0.5% |
| HALEON PLC | 248.7 | -0.4% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,278 | 1.8% | 0.2% |
| DOW JONES INDUS. AVG | 31,959 | 1.0% | -9.8% |
| DAX INDEX | 13,017 | 3.1% | -19.3% |
| NIKKEI 225 | 27,651 | 0.0% | -5.1% |
| S&P/ASX 200 INDEX | 6,829 | -0.3% | -8.8% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 88.30 | 1.95% |
| Brent Crude (ICE) | USD/bbl. | 94.27 | 2.07% |
| Gold Spot | USD/t oz. | 1,716 | 1.1% |
| Copper (Comex) | USd/lb. | 345 | 1.1% |
Click graph to enlarge
The UK 100 is called to open -60 points this morning at 7221. The UK 100 looks set to fall on the open this morning following the sharp falls in the US on Friday and news that Russia is suspending gas deliveries via the Nord Stream 1 pipeline indefinitely. On Friday, the Dow closed down 338 points, 1.1%, at 31,319, the Nasdaq lost 154 points, 1.3%, to 11,631 and the S&P slipped 42 points, 1.1%, to 3,924. In London, the confirmation of a new Prime Minister will take centre stage with Liz Truss expected to be confirmed as Boris Johnson’s replacement
Aston Martin confirms its plan for £575.8m 4-for-1 rights issue. Half of the new cash will be used to repay debt and the rest will be used to maintain liquidity cushion. The new shares will be issued at 103p, representing a 79% discount to Friday's close.
AstraZeneca's drug Forxiga has been approved in China for chronic kidney disease treatment. Imfinzi has also been approved for billary tract cancer in the USA.
Dechra Pharmaceuticals reports that their FY revenue increased 13% to £681.8m as their FY pretax profit nudged higher to £77.6m. They have increased their FY dividend per share by 11% to 44.89p.
Countryside & Vistry are nearing a deal to form a $3.2bn residential developer.
Dechra Pharmaceuticals
Ashtead Group
Capricorn Energy
NCC Group
Chinese Caixin Services PMI
German S&P Global/BME Composite PMI
EU S&P Global Composite PMI
UK S&P Global/CIPS Composite PMI
EU Retail Sales
BoE's Mann speech
UK BRC Like-For-Like Retail Sales
Japanese Overall Household Spending
UK 100 companies going ex-dividend on 8th September 2022:
Croda International
CRH
UK 250 companies going ex-dividend on 8th September 2022:
BBGI Global Infrastructure S.A.
Harbour Energy
CLS Holdings
Grafton Group
Assura
Temple Bar Investment Trust
Derwent London
XP Power
Baltic Classifieds Group
Greggs
Serco Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.